Description
Seeking men and women aged 18 to 65 with relapsing multiple sclerosis who have either not started, or have discontinued treatment with a disease modifying therapy for a study of an investigational drug.
Overview
Participants in this study will receive the investigational drug as an intravenous infusion. Depending on which group participants are assigned to the infusions may take between 1 and 4 hours. There will be at least 5 study visits over 48 weeks.
What we're hoping for
We are studying whether an investigational drug is effective and well tolerated for people with relapsing multiple sclerosis who have not started or have stopped their disease modifying therapy.
Additional Information
ClinicalTrials.gov Identifier: NCT05877963